CRVS icon

Corvus Pharmaceuticals
CRVS

Overview Fund Trends Analyst Outlook Journalist POV

31 hedge funds and large institutions have $228M invested in Corvus Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 31 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$76.2M
2
+$45.7M
3
+$31.8M
4
ASP
Adams Street Partners
Illinois
+$29.2M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$8.95M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$76.2M
2
$45.7M
3
$31.8M
4
$29.2M
5
$8.95M
6
$6.63M
7
$6.58M
8
$3.1M
9
$2.74M
10
$2.64M
11
$1.81M
12
$1.74M
13
$1.74M
14
$1.67M
15
$1.61M
16
$1.23M
17
$1.08M
18
$870K
19
$725K
20
$590K
21
$386K
22
$290K
23
$261K
24
$174K
25
$145K
1
2